Skip to content

Content transparency

  • Published:
  • Updated:
  • Editorial record: · no verified named reviewer is attached
  • Sources: 4 references listed
Authorship, review and conflicts
Named author
No verified public author identity is recorded for this page. Dog Tumor is the publisher; no veterinary authorship is implied.
Clinical review
No verified named veterinary or subject-matter reviewer is recorded for this page.
Conflicts
No page-specific conflict statement is recorded. Read the editorial standards.
Journal

Canine Insulinoma: Pair Biochemistry With Localization and a Hypoglycemia Safety Plan

Clinical Review
Editorial source check: Dog Tumor Editorial Team (editorial review; not licensed veterinary review)Last reviewed: Aug 12, 2026

Summary

Intermittent weakness, collapse, confusion, or seizures may reflect hypoglycemia; paired glucose and insulin address inappropriate secretion, while imaging answers localization and staging.

Article

Evidence-informed clinical review. Insulinoma is a functional pancreatic neuroendocrine tumor that can release insulin despite low blood glucose. Clinical episodes may be intermittent and can resemble seizure, cardiac, behavioral, or orthopedic disease. A normal glucose value between events does not erase a credible history, but fasting a suspected patient without medical supervision can be dangerous.

The clinical question

The workup must first confirm genuine hypoglycemia and consider competing causes. It then asks whether insulin is inappropriately present during hypoglycemia and where pancreatic and metastatic lesions are located. The family also needs an immediate, patient-specific plan for recurrent neurologic or collapse episodes.

What current evidence can establish

Paired laboratory measurement of glucose and insulin during an appropriate episode supports the biochemical diagnosis; interpretation is more informative than either value alone. Contrast-enhanced CT can aid pancreatic localization and staging, while ultrasound may evaluate liver or nodes and guide selected sampling. Definitive tumor classification relies on tissue when safely available.

A decision-focused pathway

Confirm sample handling and repeat unexpected low values when clinically safe, because laboratory artifact can mislead. Review liver function, adrenal disease, sepsis, medication exposure, other tumors, and nutritional history as alternate causes. Once insulinoma is supported, coordinate imaging, anesthesia, surgery, and perioperative glucose management rather than treating these as separate appointments.

Surgery and medical management address different components of the disease and may be used at different times. The written plan should cover meals, activity, prescribed medicines, glucose monitoring if recommended, episode recognition, emergency contact, and what constitutes progression. Owners should receive instructions tailored to their dog, not a generic internet rescue recipe.

Evidence gaps and interpretation

Small functional tumors can produce severe signs yet be difficult to see, and imaging sensitivity depends on technique and expertise. Absence of visible metastasis does not exclude microscopic spread. Studies of surgical and medical outcomes involve selected cases, so a group median cannot predict the course of one dog.

Safety, monitoring, and escalation

A seizure, collapse, severe confusion, inability to swallow, or failure to recover requires emergency veterinary care. Food or liquid should not be forced into the mouth of a poorly conscious or seizing dog. Deliberate fasting, medication changes, and home glucose interventions must follow the treating team’s explicit directions.

Confirm inappropriate insulin activity before localization

Episodic weakness, trembling, disorientation, collapse, or seizures can be compatible with hypoglycemia but are not specific to insulinoma. The key biochemical question is whether insulin is inappropriately present when a reliable blood sample documents low glucose, interpreted with the dog's clinical state and other causes of hypoglycemia. A normal value obtained when glucose is not low does not answer that paired question.

Imaging then serves localization and staging rather than replacing biochemical confirmation. Pancreatic lesions may be small, and a negative study does not automatically overturn a well-supported biochemical concern. The family also needs a veterinarian-written safety plan for recurrent neurologic signs while evaluation proceeds, including what constitutes an emergency and whom to contact. Recording timing, meals, activity, signs, and measured glucose when professionally directed can help connect intermittent episodes to the diagnostic record.

Questions for the veterinary team

  • Was insulin measured during confirmed hypoglycemia?
  • Which alternative causes have been considered?
  • What imaging best localizes and stages this case?
  • What is the written plan for another episode?
  • How will surgery and medical management be coordinated?

Medical disclaimer: This article is educational and cannot diagnose, treat, or determine prognosis for an individual dog. It does not replace an examination or an individualized plan from a licensed veterinarian.

Sources and further reading